Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
US8158627B2 · kind B2 · utility
4Cited by
27References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2007 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | Sep 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions, conjugates and methods comprising pyridazine compounds and cholinesterase inhibitors for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.